CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults [Phase 3]

Phase 3 passive immunotherapy trial for hospitalized adults with COVID-19 completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vanderbilt University Medical Center | Conditions: COVID-19, Coronavirus | Phase 3 | Status: COMPLETED | Results posted: 2022-11-03